ALLHAT: What has it taught us so far?

被引：7

作者：

Leenen, FHH ^{[1
]}

机构：

[1] Univ Ottawa, Inst Heart, Ottawa, ON, Canada

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2004年 / 171卷 / 07期

关键词：

D O I：

10.1503/cmaj.1031010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：719 / 720

页数：2

共 9 条

[1] A new approach for measuring quality of care for women with hypertension [J].

Asch, SM ;

Kerr, EA ;

Lapuerta, P ;

Law, A ;

McGlynn, EA .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (10) :1329-1335

[2] ALLHAT: Setting the record straight [J].

Davis, BR ;

Furberg, CD ;

Wright, JT ;

Cutler, JA ;

Whelton, P .

ANNALS OF INTERNAL MEDICINE, 2004, 141 (01) :39-46

[3]

Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981

[4]

Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178

[5] ALLHAT, or the soft science of the secondary end point [J].

Messerli, FH .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (09) :777-780

[6]

Nestico PF, 2004, JAMA-J AM MED ASSOC, V291, P2196

[7] Validation of heart failure events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants assigned to doxazosin and chlorthalidone [J].

Piller, LB ;

Davis, BR ;

Cutler, JA ;

Cushman, WC ;

Wright, JT ;

Williamson, JD ;

Leenen, FH ;

Einhorn, PT ;

Randall, OS ;

Golden, JS ;

Haywood, LJ .

CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2002, 3 (1)

[8] Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003 [J].

Staessen, JA ;

Wang, JG ;

Thijs, L .

JOURNAL OF HYPERTENSION, 2003, 21 (06) :1055-1076

[9]

Turnbull F, 2003, LANCET, V362, P1527

← 1 →